Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS

Clinical trial NCT03502668 · COMPLETED

Trial details

NCT number: NCT03502668
Sponsor: Taiho Oncology, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2018-07-27
Primary completion: 2026-01-13
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.